- Title
- Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
- Creators
- Bradley J. Monk (Author) - Creighton UniversityP. Ghatage (Author)T. Parekh (Author)E. Henitz (Author)R. Knoblauch (Author)A. S. Matos-Pita (Author)A. Nieto (Author)Y. C. Park (Author)P. S. Cheng (Author)W. Li (Author)R. Favis (Author)D. Ricci (Author)A. Poveda (Author)
- Additional links
- http://doi.org/10.1093/annonc/mdv071
- Publication Details
- Annals of Oncology, Vol.26(5), pp.914-920
- Publisher
- . Published by Oxford University Press on behalf of the European Society for Medical Oncology
- Number of pages
- 914-920
- Identifiers
- 991005932648302656
- Academic Unit
- School of Medicine; Obstetrics & Gynecology; General Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
Annals of Oncology, Vol.26(5), pp.914-920
05/2015
PMID: 25722380
Metrics
5 Record Views